EMBRYONIC–ONCOLOGIC SIGNALING INTEGRATION

This project proposes an integrative systems-biology hypothesis connecting embryonic developmental signaling networks with tumor plasticity mechanisms. Increasing evidence suggests that cancer cells partially reactivate pathways fundamental to embryogenesis, including WNT, Notch, TGF-β, PI3K/AKT, and metabolic programs associated with early development. In embryogenesis, these pathways function under strict spatial and temporal regulatory control, coordinating proliferation, differentiation, apoptosis, and metabolic balance. In contrast, tumors appear to represent a deregulated reactivation of these networks, lacking synchronized regulatory architecture. The project introduces the Regulatory Developmental Rebalancing Model (RDRM), which conceptualizes cancer as a vertically desynchronized system involving genetic activation, epigenetic instability, metabolic reprogramming, and microenvironmental adaptation. Rather than focusing exclusively on cytotoxic elimination, the framework explores the possibility of restoring regulatory synchronization to redirect tumor plasticity toward controlled differentiation and apoptotic responsiveness. The hypothesis is positioned within the fields of developmental oncology, cancer systems biology, and epigenetic reprogramming. It proposes experimentally testable strategies involving organoid models, controlled pathway modulation, and multi-layer transcriptomic analysis. This work does not claim therapeutic readiness but aims to provide a conceptual systems framework to guide future experimental investigation.